We observed relatively lower circulating adiponectin in centrally obese subjects with the clustering of 4 MetS risk factors as compared to the subjects with only central obesity, with the clustering of 4 MetS risk factors or without any MetS risk factors. This evidence concerns the gene ADIPOQ and metabolic syndrome.